Tazarotene and corticosteroid treatment for psoriasis
View Patent ↗The present invention provides a method for treating proliferative skin diseases comprising the administration of an effective amount of tazarotene and an effective amount of a corticosteroid. This invention is especially useful for treating psoriasis.
1. A method for treating proliferative skin diseases comprising the administration of an effective amount of tazarotene and an effective amount of a high-potency corticosteroid.
2. The method of claim 1 wherein said corticosteroid is selected from the group consisting of mometasone furoate, fluocinonide, and betamethasone valerate.
3. The method of claim 1 wherein tazarotene is applied as a 0.1% gel.
4. A method for treating psoriasis in a human subject by topically applying to the psoriatic skin of said subject an effective amount of tazarotene and an effective amount of a high-potency corticosteroid.
5. The method of claim 4 wherein tazarotene is applied as a 0.1% gel.
6. The method of claim 5 wherein said corticosteroid is a cream.
7. The method of claim 4 wherein said corticosteroid is selected from the group consisting of mometasone furoate and fluocinonide.
8. The method of claim 1 wherein tazarotene is administered once daily in the evening and the corticosteroid is administered once daily in the morning.